Alger Health Sciences A holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Alger Health Sciences Fund Class A AHSAX
- NAV / 1-Day Return 28.55 / −0.21 %
- Total Assets 83.8M
-
Adj. Expense Ratio
1.170%
- Expense Ratio 1.170%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 289%
USD | NAV as of Aug 19, 2026 | 1-Day Return as of Aug 19, 2026, 12:44 AM GMT+0
Morningstar’s Analysis AHSAX
Will AHSAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 37.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Impulse Dynamics Ireland Series F-3 | 4.90 | 3M | — |
Bruker Corp | 4.56 | 3M | Healthcare |
Teva Pharmaceutical Industries Ltd ADR | 4.55 | 3M | Healthcare |
Merck & Co Inc | 4.40 | 3M | Healthcare |
CVS Health Corp | 3.46 | 2M | Healthcare |
Eli Lilly and Co | 3.44 | 2M | Healthcare |
Novo Nordisk AS ADR | 3.20 | 2M | Healthcare |
Forte Biosciences Inc Ordinary Shares | 3.02 | 2M | Healthcare |
Welltower Inc | 3.01 | 2M | Real Estate |
Guardant Health Inc | 2.96 | 2M | Healthcare |
United States